Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
Abroad (travel likely)CompletedPHASE3
Conditions
Type 1 Diabetes Mellitus
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ECMC Ambulatory Center, 3rd Floor, Buffalo, New York, United States
Study leads
Nitesh D Kuhadiya, MD, MPH
Principal Investigator
University at Buffalo